+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Flow Cytometer Market 2023-2027

  • PDF Icon

    Report

  • 168 Pages
  • February 2023
  • Region: Global
  • TechNavio
  • ID: 5232244
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The flow cytometer market is forecast to grow by $6.04 billion during 2022-2027, accelerating at a CAGR of 13.12% during the forecast period.

The market is driven by increasing expenditure on R&D, a growing number of applications for flow cytometers, and technological advances.

This study identifies the increasing level of process automation as one of the prime reasons driving the flow cytometer market growth during the next few years. Also, outsourcing of drug discovery process and rapid growth potential in emerging economies will lead to sizable demand in the market.

The report on the flow cytometer market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering key vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. 

The flow cytometer market is segmented as below:

By Product

  • Reagents and consumables
  • Instruments
  • Others

By End-user

  • Pharmaceutical industry
  • Health and diagnostic centers
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)


The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the flow cytometer market covers the following areas:

  • Flow cytometer market sizing
  • Flow cytometer market forecast
  • Flow cytometer market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading flow cytometer market vendors that include Abbott Laboratories, Agilent Technologies Inc., Amphasys AG, Apogee Flow Systems Ltd., Becton Dickinson and Co., Bio Rad Laboratories Inc., Cytek Biosciences Inc., Danaher Corp., DiaSorin SpA, Enzo Biochem Inc., Miltenyi Biotec B.V. and Co. KG, Mindray Bio medical Electronics Co. Ltd, OLS OMNI Life Science GmbH and Co. KG, Onchip Biotechnology Co. Ltd.Corp., Sartorius AG, Sony Group Corp., Stratedigm Inc., Sysmex Corp., Thermo Fisher Scientific Inc., and Union Biometrica Inc. Also, the flow cytometer market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The publisher's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
  • Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
  • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global flow cytometer market 2017 - 2021
  • Exhibit 18: Historic Market Size - Data Table on Global flow cytometer market 2017 - 2021 ($ million)
4.2 Product Segment Analysis 2017 - 2021
  • Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.3 End-user Segment Analysis 2017 - 2021
  • Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
  • Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
  • Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Product
6.1 Market segments
  • Exhibit 30: Chart on Product - Market share 2022-2027 (%)
  • Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
6.2 Comparison by Product
  • Exhibit 32: Chart on Comparison by Product
  • Exhibit 33: Data Table on Comparison by Product
6.3 Reagents and consumables - Market size and forecast 2022-2027
  • Exhibit 34: Chart on Reagents and consumables - Market size and forecast 2022-2027 ($ million)
  • Exhibit 35: Data Table on Reagents and consumables - Market size and forecast 2022-2027 ($ million)
  • Exhibit 36: Chart on Reagents and consumables - Year-over-year growth 2022-2027 (%)
  • Exhibit 37: Data Table on Reagents and consumables - Year-over-year growth 2022-2027 (%)
6.4 Instruments - Market size and forecast 2022-2027
  • Exhibit 38: Chart on Instruments - Market size and forecast 2022-2027 ($ million)
  • Exhibit 39: Data Table on Instruments - Market size and forecast 2022-2027 ($ million)
  • Exhibit 40: Chart on Instruments - Year-over-year growth 2022-2027 (%)
  • Exhibit 41: Data Table on Instruments - Year-over-year growth 2022-2027 (%)
6.5 Others - Market size and forecast 2022-2027
  • Exhibit 42: Chart on Others - Market size and forecast 2022-2027 ($ million)
  • Exhibit 43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
  • Exhibit 44: Chart on Others - Year-over-year growth 2022-2027 (%)
  • Exhibit 45: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by Product
  • Exhibit 46: Market opportunity by Product ($ million)
7 Market Segmentation by End-user
7.1 Market segments
  • Exhibit 47: Chart on End-user - Market share 2022-2027 (%)
  • Exhibit 48: Data Table on End-user - Market share 2022-2027 (%)
7.2 Comparison by End-user
  • Exhibit 49: Chart on Comparison by End-user
  • Exhibit 50: Data Table on Comparison by End-user
7.3 Pharmaceutical industry - Market size and forecast 2022-2027
  • Exhibit 51: Chart on Pharmaceutical industry - Market size and forecast 2022-2027 ($ million)
  • Exhibit 52: Data Table on Pharmaceutical industry - Market size and forecast 2022-2027 ($ million)
  • Exhibit 53: Chart on Pharmaceutical industry - Year-over-year growth 2022-2027 (%)
  • Exhibit 54: Data Table on Pharmaceutical industry - Year-over-year growth 2022-2027 (%)
7.4 Health and diagnostic centers - Market size and forecast 2022-2027
  • Exhibit 55: Chart on Health and diagnostic centers - Market size and forecast 2022-2027 ($ million)
  • Exhibit 56: Data Table on Health and diagnostic centers - Market size and forecast 2022-2027 ($ million)
  • Exhibit 57: Chart on Health and diagnostic centers - Year-over-year growth 2022-2027 (%)
  • Exhibit 58: Data Table on Health and diagnostic centers - Year-over-year growth 2022-2027 (%)
7.5 Others - Market size and forecast 2022-2027
  • Exhibit 59: Chart on Others - Market size and forecast 2022-2027 ($ million)
  • Exhibit 60: Data Table on Others - Market size and forecast 2022-2027 ($ million)
  • Exhibit 61: Chart on Others - Year-over-year growth 2022-2027 (%)
  • Exhibit 62: Data Table on Others - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by End-user
  • Exhibit 63: Market opportunity by End-user ($ million)
8 Customer Landscape
8.1 Customer landscape overview
  • Exhibit 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
  • Exhibit 65: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibit 66: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
  • Exhibit 67: Chart on Geographic comparison
  • Exhibit 68: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
  • Exhibit 69: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 70: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 71: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibit 72: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
  • Exhibit 73: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 74: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 75: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibit 76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
  • Exhibit 77: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 78: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 79: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibit 80: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
  • Exhibit 81: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 82: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 83: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibit 84: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
  • Exhibit 85: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 86: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 87: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibit 88: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 China - Market size and forecast 2022-2027
  • Exhibit 89: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 90: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 91: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibit 92: Data Table on China - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
  • Exhibit 93: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 95: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibit 96: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 Germany - Market size and forecast 2022-2027
  • Exhibit 97: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 98: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 99: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibit 100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.11 Canada - Market size and forecast 2022-2027
  • Exhibit 101: Chart on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibit 102: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibit 103: Chart on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibit 104: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
  • Exhibit 105: Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
  • Exhibit 106: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
  • Exhibit 107: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
  • Exhibit 108: Overview on factors of disruption
11.4 Industry risks
  • Exhibit 109: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
  • Exhibit 110: Vendors covered
12.2 Market positioning of vendors
  • Exhibit 111: Matrix on vendor position and classification
12.3 Agilent Technologies Inc.
  • Exhibit 112: Agilent Technologies Inc. - Overview
  • Exhibit 113: Agilent Technologies Inc. - Business segments
  • Exhibit 114: Agilent Technologies Inc. - Key news
  • Exhibit 115: Agilent Technologies Inc. - Key offerings
  • Exhibit 116: Agilent Technologies Inc. - Segment focus
12.4 Amphasys AG
  • Exhibit 117: Amphasys AG - Overview
  • Exhibit 118: Amphasys AG - Product/Service
  • Exhibit 119: Amphasys AG - Key offerings
12.5 Apogee Flow Systems Ltd.
  • Exhibit 120: Apogee Flow Systems Ltd. - Overview
  • Exhibit 121: Apogee Flow Systems Ltd. - Product/Service
  • Exhibit 122: Apogee Flow Systems Ltd. - Key offerings
12.6 Becton Dickinson and Co.
  • Exhibit 123: Becton Dickinson and Co. - Overview
  • Exhibit 124: Becton Dickinson and Co. - Business segments
  • Exhibit 125: Becton Dickinson and Co. - Key news
  • Exhibit 126: Becton Dickinson and Co. - Key offerings
  • Exhibit 127: Becton Dickinson and Co. - Segment focus
12.7 Bio Rad Laboratories Inc.
  • Exhibit 128: Bio Rad Laboratories Inc. - Overview
  • Exhibit 129: Bio Rad Laboratories Inc. - Business segments
  • Exhibit 130: Bio Rad Laboratories Inc. - Key news
  • Exhibit 131: Bio Rad Laboratories Inc. - Key offerings
  • Exhibit 132: Bio Rad Laboratories Inc. - Segment focus
12.8 Cytek Biosciences Inc.
  • Exhibit 133: Cytek Biosciences Inc. - Overview
  • Exhibit 134: Cytek Biosciences Inc. - Product/Service
  • Exhibit 135: Cytek Biosciences Inc. - Key offerings
12.9 Danaher Corp.
  • Exhibit 136: Danaher Corp. - Overview
  • Exhibit 137: Danaher Corp. - Business segments
  • Exhibit 138: Danaher Corp. - Key news
  • Exhibit 139: Danaher Corp. - Key offerings
  • Exhibit 140: Danaher Corp. - Segment focus
12.10 DiaSorin SpA
  • Exhibit 141: DiaSorin SpA - Overview
  • Exhibit 142: DiaSorin SpA - Business segments
  • Exhibit 143: DiaSorin SpA - Key news
  • Exhibit 144: DiaSorin SpA - Key offerings
  • Exhibit 145: DiaSorin SpA - Segment focus
12.11 Enzo Biochem Inc.
  • Exhibit 146: Enzo Biochem Inc. - Overview
  • Exhibit 147: Enzo Biochem Inc. - Product/Service
  • Exhibit 148: Enzo Biochem Inc. - Key offerings
12.12 Miltenyi Biotec B.V. and Co. KG
  • Exhibit 149: Miltenyi Biotec B.V. and Co. KG - Overview
  • Exhibit 150: Miltenyi Biotec B.V. and Co. KG - Product/Service
  • Exhibit 151: Miltenyi Biotec B.V. and Co. KG - Key news
  • Exhibit 152: Miltenyi Biotec B.V. and Co. KG - Key offerings
12.13 Sartorius AG
  • Exhibit 153: Sartorius AG - Overview
  • Exhibit 154: Sartorius AG - Business segments
  • Exhibit 155: Sartorius AG - Key news
  • Exhibit 156: Sartorius AG - Key offerings
  • Exhibit 157: Sartorius AG - Segment focus
12.14 Sony Group Corp.
  • Exhibit 158: Sony Group Corp. - Overview
  • Exhibit 159: Sony Group Corp. - Business segments
  • Exhibit 160: Sony Group Corp. - Key news
  • Exhibit 161: Sony Group Corp. - Key offerings
  • Exhibit 162: Sony Group Corp. - Segment focus
12.15 Stratedigm Inc.
  • Exhibit 163: Stratedigm Inc. - Overview
  • Exhibit 164: Stratedigm Inc. - Product/Service
  • Exhibit 165: Stratedigm Inc. - Key offerings
12.16 Sysmex Corp.
  • Exhibit 166: Sysmex Corp. - Overview
  • Exhibit 167: Sysmex Corp. - Business segments
  • Exhibit 168: Sysmex Corp. - Key offerings
  • Exhibit 169: Sysmex Corp. - Segment focus
12.17 Thermo Fisher Scientific Inc.
  • Exhibit 170: Thermo Fisher Scientific Inc. - Overview
  • Exhibit 171: Thermo Fisher Scientific Inc. - Business segments
  • Exhibit 172: Thermo Fisher Scientific Inc. - Key news
  • Exhibit 173: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibit 174: Thermo Fisher Scientific Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
  • Exhibit 175: Inclusions checklist
  • Exhibit 176: Exclusions checklist
13.3 Currency conversion rates for US$
  • Exhibit 177: Currency conversion rates for US$
13.4 Research methodology
  • Exhibit 178: Research methodology
  • Exhibit 179: Validation techniques employed for market sizing
  • Exhibit 180: Information sources
13.5 List of abbreviations
  • Exhibit 181: List of abbreviations
Exhibit:
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 5: Executive Summary - Chart on Market Segmentation by Product
Exhibit 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 7: Executive Summary - Chart on Incremental Growth
Exhibit 8: Executive Summary - Data Table on Incremental Growth
Exhibit 9: Executive Summary - Chart on Vendor Market Positioning
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
Exhibit 12: Offerings of vendors included in the market definition
Exhibit 13: Market segments
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 18: Historic Market Size - Data Table on Global flow cytometer market 2017 - 2021 ($ million)
Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
Exhibit 30: Chart on Product - Market share 2022-2027 (%)
Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
Exhibit 34: Chart on Reagents and consumables - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Reagents and consumables - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Reagents and consumables - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Reagents and consumables - Year-over-year growth 2022-2027 (%)
Exhibit 38: Chart on Instruments - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Instruments - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Instruments - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Instruments - Year-over-year growth 2022-2027 (%)
Exhibit 42: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibit 46: Market opportunity by Product ($ million)
Exhibit 47: Chart on End-user - Market share 2022-2027 (%)
Exhibit 48: Data Table on End-user - Market share 2022-2027 (%)
Exhibit 49: Chart on Comparison by End-user
Exhibit 50: Data Table on Comparison by End-user
Exhibit 51: Chart on Pharmaceutical industry - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Data Table on Pharmaceutical industry - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Chart on Pharmaceutical industry - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Pharmaceutical industry - Year-over-year growth 2022-2027 (%)
Exhibit 55: Chart on Health and diagnostic centers - Market size and forecast 2022-2027 ($ million)
Exhibit 56: Data Table on Health and diagnostic centers - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Chart on Health and diagnostic centers - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Health and diagnostic centers - Year-over-year growth 2022-2027 (%)
Exhibit 59: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 60: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 62: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibit 63: Market opportunity by End-user ($ million)
Exhibit 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 65: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 66: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 67: Chart on Geographic comparison
Exhibit 68: Data Table on Geographic comparison
Exhibit 69: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 70: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 71: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 72: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibit 73: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 77: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 81: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 85: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibit 89: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibit 93: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibit 97: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 99: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 101: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 102: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 103: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 104: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 105: Market opportunity By Geographical Landscape ($ million)
Exhibit 106: Impact of drivers and challenges in 2022 and 2027
Exhibit 107: Overview on Criticality of inputs and Factors of differentiation
Exhibit 108: Overview on factors of disruption
Exhibit 109: Impact of key risks on business
Exhibit 110: Vendors covered
Exhibit 111: Matrix on vendor position and classification
Exhibit 112: Agilent Technologies Inc. - Overview
Exhibit 113: Agilent Technologies Inc. - Business segments
Exhibit 114: Agilent Technologies Inc. - Key news
Exhibit 115: Agilent Technologies Inc. - Key offerings
Exhibit 116: Agilent Technologies Inc. - Segment focus
Exhibit 117: Amphasys AG - Overview
Exhibit 118: Amphasys AG - Product/Service
Exhibit 119: Amphasys AG - Key offerings
Exhibit 120: Apogee Flow Systems Ltd. - Overview
Exhibit 121: Apogee Flow Systems Ltd. - Product/Service
Exhibit 122: Apogee Flow Systems Ltd. - Key offerings
Exhibit 123: Becton Dickinson and Co. - Overview
Exhibit 124: Becton Dickinson and Co. - Business segments
Exhibit 125: Becton Dickinson and Co. - Key news
Exhibit 126: Becton Dickinson and Co. - Key offerings
Exhibit 127: Becton Dickinson and Co. - Segment focus
Exhibit 128: Bio Rad Laboratories Inc. - Overview
Exhibit 129: Bio Rad Laboratories Inc. - Business segments
Exhibit 130: Bio Rad Laboratories Inc. - Key news
Exhibit 131: Bio Rad Laboratories Inc. - Key offerings
Exhibit 132: Bio Rad Laboratories Inc. - Segment focus
Exhibit 133: Cytek Biosciences Inc. - Overview
Exhibit 134: Cytek Biosciences Inc. - Product/Service
Exhibit 135: Cytek Biosciences Inc. - Key offerings
Exhibit 136: Danaher Corp. - Overview
Exhibit 137: Danaher Corp. - Business segments
Exhibit 138: Danaher Corp. - Key news
Exhibit 139: Danaher Corp. - Key offerings
Exhibit 140: Danaher Corp. - Segment focus
Exhibit 141: DiaSorin SpA - Overview
Exhibit 142: DiaSorin SpA - Business segments
Exhibit 143: DiaSorin SpA - Key news
Exhibit 144: DiaSorin SpA - Key offerings
Exhibit 145: DiaSorin SpA - Segment focus
Exhibit 146: Enzo Biochem Inc. - Overview
Exhibit 147: Enzo Biochem Inc. - Product/Service
Exhibit 148: Enzo Biochem Inc. - Key offerings
Exhibit 149: Miltenyi Biotec B.V. and Co. KG - Overview
Exhibit 150: Miltenyi Biotec B.V. and Co. KG - Product/Service
Exhibit 151: Miltenyi Biotec B.V. and Co. KG - Key news
Exhibit 152: Miltenyi Biotec B.V. and Co. KG - Key offerings
Exhibit 153: Sartorius AG - Overview
Exhibit 154: Sartorius AG - Business segments
Exhibit 155: Sartorius AG - Key news
Exhibit 156: Sartorius AG - Key offerings
Exhibit 157: Sartorius AG - Segment focus
Exhibit 158: Sony Group Corp. - Overview
Exhibit 159: Sony Group Corp. - Business segments
Exhibit 160: Sony Group Corp. - Key news
Exhibit 161: Sony Group Corp. - Key offerings
Exhibit 162: Sony Group Corp. - Segment focus
Exhibit 163: Stratedigm Inc. - Overview
Exhibit 164: Stratedigm Inc. - Product/Service
Exhibit 165: Stratedigm Inc. - Key offerings
Exhibit 166: Sysmex Corp. - Overview
Exhibit 167: Sysmex Corp. - Business segments
Exhibit 168: Sysmex Corp. - Key offerings
Exhibit 169: Sysmex Corp. - Segment focus
Exhibit 170: Thermo Fisher Scientific Inc. - Overview
Exhibit 171: Thermo Fisher Scientific Inc. - Business segments
Exhibit 172: Thermo Fisher Scientific Inc. - Key news
Exhibit 173: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 174: Thermo Fisher Scientific Inc. - Segment focus
Exhibit 175: Inclusions checklist
Exhibit 176: Exclusions checklist
Exhibit 177: Currency conversion rates for US$
Exhibit 178: Research methodology
Exhibit 179: Validation techniques employed for market sizing
Exhibit 180: Information sources
Exhibit 181: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global flow cytometer market: Abbott Laboratories, Agilent Technologies Inc., Amphasys AG, Apogee Flow Systems Ltd., Becton Dickinson and Co., Bio Rad Laboratories Inc., Cytek Biosciences Inc., Danaher Corp., DiaSorin SpA, Enzo Biochem Inc., Miltenyi Biotec B.V. and Co. KG, Mindray Bio medical Electronics Co. Ltd, OLS OMNI Life Science GmbH and Co. KG, Onchip Biotechnology Co. Ltd.Corp., Sartorius AG, Sony Group Corp., Stratedigm Inc., Sysmex Corp., Thermo Fisher Scientific Inc., and Union Biometrica Inc.

Commenting on the report, an analyst from the researcher said: 'The latest trend gaining momentum in the market is increasing level of process automation.'

According to the report, one of the major drivers for this market is the increasing expenditure on R&D.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Amphasys AG
  • Apogee Flow Systems Ltd.
  • Becton Dickinson and Co.
  • Bio Rad Laboratories Inc.
  • Cytek Biosciences Inc.
  • Danaher Corp.
  • DiaSorin SpA
  • Enzo Biochem Inc.
  • Miltenyi Biotec B.V. and Co. KG
  • Mindray Bio medical Electronics Co. Ltd
  • OLS OMNI Life Science GmbH and Co. KG
  • Onchip Biotechnology Co. Ltd.Corp.
  • Sartorius AG
  • Sony Group Corp.
  • Stratedigm Inc.
  • Sysmex Corp.
  • Thermo Fisher Scientific Inc.
  • Union Biometrica Inc.